Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.
Department of Medicine II-Infectious Diseases, HIV Center, Hospital of the J. W. Goethe University, Theodor Stern Kai 7, 60596, Frankfurt, Germany, timo.wolf@kgu.de.
T
T
Wolf
T
T
Kiderlen
J
J
Atta
C
C
Stephan
G
G
Kann
H-R
HR
Brodt
C
C
Brandts
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000601:surgery* / Q000821:virology; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D018380:Hematopoietic Stem Cell Transplantation; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000601:surgery* / Q000821:virology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D000069283:Rituximab; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; D008727:Methotrexate